Entry
Name
Diabetic cardiomyopathy - Lemur catta (Ring-tailed lemur)
Description
Diabetic cardiomyopathy has been defined as left ventricular dysfunction that occurs among patients with diabetes mellitus independent of a recognized cause such as coronary artery disease or hypertension. The pathogenesis of diabetic cardiomyopathy broadly involves hyperglycemia, increased circulating fatty acids, and insulin resistance contributing to reactive oxygen species (ROS) generation, mitochondrial dysfunction, impaired calcium metabolism, Renin-Angiotensin System (RAS) activation, and altered substrate metabolism. These effects result in cardiac fibrosis, hypertrophy, cardiomyocyte death, contractile dysfunction, endothelial cell damage and eventually heart failure. In the process of cardiac fibrosis, cardiac fibroblasts are the final effector cell.
Class
Human Diseases; Cardiovascular disease
BRITE hierarchy
Pathway map
Disease
H02498 Diabetic cardiomyopathy
Organism
Lemur catta (Ring-tailed lemur) [GN:
lcat ]
Gene
123620754 ATP5MC1; ATP synthase F(0) complex subunit C1, mitochondrial [KO:K02128 ]
123622057 PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858 ] [EC:3.1.4.11 ]
123622065 PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858 ] [EC:3.1.4.11 ]
123624079 TGFB1; transforming growth factor beta-1 proprotein isoform X1 [KO:K13375 ]
123624366 PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858 ] [EC:3.1.4.11 ]
123624681 NDUFA3; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 [KO:K03947 ]
123626606 VDAC3; voltage-dependent anion-selective channel protein 3 isoform X1 [KO:K15041 ]
123626839 TGFB2; transforming growth factor beta-2 proprotein isoform X1 [KO:K13376 ]
123626873 ATP5F1C; ATP synthase subunit gamma, mitochondrial isoform X1 [KO:K02136 ]
123627206 NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580 ]
123627225 PDHA2; pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial isoform X1 [KO:K00161 ] [EC:1.2.4.1 ]
123627700 CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515 ] [EC:2.7.11.17 ]
123628649 NDUFB11; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial [KO:K11351 ]
123628789 NDUFA1; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 [KO:K03945 ]
123629856 PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ]
123630278 PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922 ] [EC:2.7.1.153 ]
123630288 NDUFB5; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial [KO:K03961 ]
123630502 NDUFB4; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 [KO:K03960 ]
123630658 ATP5PF; ATP synthase-coupling factor 6, mitochondrial [KO:K02131 ]
123630777 NDUFV3; NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial isoform X1 [KO:K03944 ]
123631474 NDUFB10; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 [KO:K03966 ]
123631693 SMAD3; mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605 ]
123631780 AGER; advanced glycosylation end product-specific receptor isoform X1 [KO:K19722 ]
123632797 NDUFS7; NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial isoform X1 [KO:K03940 ] [EC:7.1.1.2 ]
123634267 SLC2A1; solute carrier family 2, facilitated glucose transporter member 1 [KO:K07299 ]
123634506 PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922 ] [EC:2.7.1.153 ]
123635033 ATP5PB; ATP synthase F(0) complex subunit B1, mitochondrial isoform X1 [KO:K02127 ]
123635220 NDUFS2; NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial [KO:K03935 ] [EC:7.1.1.2 ]
123635226 SDHC; succinate dehydrogenase cytochrome b560 subunit, mitochondrial [KO:K00236 ]
123635558 NDUFA7; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 isoform X1 [KO:K03951 ]
123635724 NDUFS5; NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 [KO:K03938 ]
123635928 SDHB; succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial [KO:K00235 ] [EC:1.3.5.1 ]
123636458 NDUFA11; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11 [KO:K03956 ]
123637772 VDAC1; voltage-dependent anion-selective channel protein 1 [KO:K05862 ]
123637866 NDUFA2; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 [KO:K03946 ]
123638412 NDUFA13; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 [KO:K11353 ]
123638560 NDUFC1; NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial [KO:K03967 ]
123639214 PPARA; peroxisome proliferator-activated receptor alpha isoform X1 [KO:K07294 ]
123639294 RAC2; ras-related C3 botulinum toxin substrate 2 isoform X1 [KO:K07860 ]
123639435 NDUFA12; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 [KO:K11352 ]
123639613 NDUFA4L2; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2 [KO:K03948 ]
123639706 PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649 ]
123639755 ATP5MC2; ATP synthase F(0) complex subunit C2, mitochondrial [KO:K02128 ]
123640141 NDUFA9; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial [KO:K03953 ]
123640284 NDUFA6; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 [KO:K03950 ]
123641430 PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 isoform X1 [KO:K05858 ] [EC:3.1.4.11 ]
123641691 SDHD; succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial isoform X1 [KO:K00237 ]
123642684 NDUFS3; NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial [KO:K03936 ] [EC:7.1.1.2 ]
123642823 NDUFS8; NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial [KO:K03941 ] [EC:7.1.1.2 ]
123643524 NDUFA10; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial [KO:K03954 ]
123643900 NDUFB3; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 [KO:K03959 ]
123644027 ATP5MC3; ATP synthase F(0) complex subunit C3, mitochondrial [KO:K02128 ]
123644439 NDUFB9; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 [KO:K03965 ]
123645245 NDUFB1; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1 isoform X1 [KO:K03957 ]
123645738 NDUFA8; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 [KO:K03952 ]
123646230 NDUFB6; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 [KO:K03962 ]
123646372 PTPA; serine/threonine-protein phosphatase 2A activator isoform X1 [KO:K17605 ]
123646462 TGFB3; transforming growth factor beta-3 proprotein isoform X1 [KO:K13377 ]
123647452 NDUFA5; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 [KO:K03949 ]
123647608 CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515 ] [EC:2.7.11.17 ]
123647646 NDUFB2; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial [KO:K03958 ]
123648206 NDUFS6; NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial isoform X1 [KO:K03939 ]
123648345 SDHA; succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial isoform X1 [KO:K00234 ] [EC:1.3.5.1 ]
123648578 PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649 ]
123648644 NDUFS4; NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial [KO:K03937 ]
123650126 NDUFB8; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial isoform X1 [KO:K03964 ]
123650270 VDAC2; voltage-dependent anion-selective channel protein 2 [KO:K15040 ]
123650285 CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515 ] [EC:2.7.11.17 ]
123650860 SLC2A4; solute carrier family 2, facilitated glucose transporter member 4 isoform X1 [KO:K07191 ]
Compound
C00043 UDP-N-acetyl-alpha-D-glucosamine
C00118 D-Glyceraldehyde 3-phosphate
C00236 3-Phospho-D-glyceroyl phosphate
C00352 D-Glucosamine 6-phosphate
C05981 Phosphatidylinositol-3,4,5-trisphosphate
C06156 alpha-D-Glucosamine 1-phosphate
C21011 [Protein]-N(epsilon)-(carboxymethyl)lysine
C21012 [Protein]-N(epsilon)-(carboxyethyl)lysine
Reference
Authors
Riehle C, Bauersachs J
Title
Of mice and men: models and mechanisms of diabetic cardiomyopathy.
Journal
Reference
Authors
Huynh K, Bernardo BC, McMullen JR, Ritchie RH
Title
Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.
Journal
Reference
Authors
Lorenzo-Almoros A, Tunon J, Orejas M, Cortes M, Egido J, Lorenzo O
Title
Diagnostic approaches for diabetic cardiomyopathy.
Journal
Reference
Authors
Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L
Title
Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.
Journal
Reference
Authors
Zamora M, Villena JA
Title
Contribution of Impaired Insulin Signaling to the Pathogenesis of Diabetic Cardiomyopathy.
Journal
Reference
Authors
Palomer X, Pizarro-Delgado J, Vazquez-Carrera M
Title
Emerging Actors in Diabetic Cardiomyopathy: Heartbreaker Biomarkers or Therapeutic Targets?
Journal
Reference
Authors
Mishra PK, Ying W, Nandi SS, Bandyopadhyay GK, Patel KK, Mahata SK
Title
Diabetic Cardiomyopathy: An Immunometabolic Perspective.
Journal
Reference
Authors
Chong CR, Clarke K, Levelt E
Title
Metabolic Remodeling in Diabetic Cardiomyopathy.
Journal
Reference
Authors
Brownlee M
Title
Biochemistry and molecular cell biology of diabetic complications.
Journal
Reference
Authors
Gollmer J, Zirlik A, Bugger H
Title
Established and Emerging Mechanisms of Diabetic Cardiomyopathy.
Journal
Reference
Authors
Boudina S, Abel ED
Title
Diabetic cardiomyopathy revisited.
Journal
Reference
Authors
Varma U, Koutsifeli P, Benson VL, Mellor KM, Delbridge LMD
Title
Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.
Journal
Reference
Authors
Mandavia CH, Aroor AR, Demarco VG, Sowers JR
Title
Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.
Journal
Reference
Authors
Falcao-Pires I, Leite-Moreira AF
Title
Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.
Journal
Reference
Authors
Westermeier F, Riquelme JA, Pavez M, Garrido V, Diaz A, Verdejo HE, Castro PF, Garcia L, Lavandero S
Title
New Molecular Insights of Insulin in Diabetic Cardiomyopathy.
Journal
Reference
Authors
Randhawa VK, Dhanvantari S, Connelly K
Title
How Diabetes and Heart Failure Modulate Each Other and Condition Management.
Journal
Reference
Authors
Athithan L, Gulsin GS, McCann GP, Levelt E
Title
Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date.
Journal
Reference
Authors
Murarka S, Movahed MR
Title
Diabetic cardiomyopathy.
Journal
Reference
Authors
Thomas CM, Yong QC, Rosa RM, Seqqat R, Gopal S, Casarini DE, Jones WK, Gupta S, Baker KM, Kumar R
Title
Cardiac-specific suppression of NF-kappaB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system.
Journal
Reference
Authors
Brahma MK, Pepin ME, Wende AR
Title
My Sweetheart Is Broken: Role of Glucose in Diabetic Cardiomyopathy.
Journal
Reference
Authors
Singh VP, Le B, Khode R, Baker KM, Kumar R
Title
Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis.
Journal
Reference
Authors
Singh VP, Baker KM, Kumar R
Title
Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production.
Journal
Reference
Authors
Jia G, DeMarco VG, Sowers JR
Title
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.
Journal
Reference
Authors
Kim JA, Wei Y, Sowers JR
Title
Role of mitochondrial dysfunction in insulin resistance.
Journal
Reference
Authors
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuniga FA
Title
Association between insulin resistance and the development of cardiovascular disease.
Journal
Reference
Authors
Evangelista I, Nuti R, Picchioni T, Dotta F, Palazzuoli A
Title
Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy.
Journal
Reference
Authors
Joshi M, Kotha SR, Malireddy S, Selvaraju V, Satoskar AR, Palesty A, McFadden DW, Parinandi NL, Maulik N
Title
Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria.
Journal
Reference
Authors
Knapp M, Tu X, Wu R
Title
Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.
Journal
Reference
Authors
Asbun J, Villarreal FJ
Title
The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy.
Journal
Reference
Authors
Levick SP, Widiapradja A
Title
The Diabetic Cardiac Fibroblast: Mechanisms Underlying Phenotype and Function.
Journal
Related pathway
lcat00520 Amino sugar and nucleotide sugar metabolism
lcat04933 AGE-RAGE signaling pathway in diabetic complications
KO pathway